Pancreatic Acinar Cell Carcinoma Active Not Recruiting Phase 3 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0040329 (Pancreatic Acinar Cell Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryTreatment